Using ultrasound and AI to diagnose sarcopenia in older adults
Official title: An Artificial Intelligence Assessment System for Risk Grading of Sarcopenia Based on Ultrasonographic Multidimensional Data
Run by West China Hospital · NCT06199856 · Data updated 2026-11-12
This study is testing if using ultrasound and artificial intelligence can help doctors better diagnose muscle loss in older adults to improve their health and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 100 Years |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | West China Hospital Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Status | Recruiting |
| Started | October 1, 2020 |
| Main results expected | December 2027 |
| Study ends | December 2028 |
| Registry record updated | March 14, 2025 |
| Trial ID | NCT06199856 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals over 50 years of age who exhibit signs of suspected sarcopenia.
✕Probably not a fit
Patients with amputations, severe edema, or other significant health issues that prevent participation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to develop an artificial intelligence-assisted diagnostic model for sarcopenia using ultrasound images. It focuses on creating classification and regression models that can aid in diagnosing sarcopenia, estimating patient strength, and performing other related functions based on ultrasound data. Sarcopenia is a significant concern for older adults, as it involves the loss of muscle mass and function, which can worsen the prognosis of various diseases. By identifying sarcopenia early, the study seeks to improve the quality of life for older individuals.
Why it matters
Potential benefit: If successful, this approach could lead to earlier and more accurate diagnoses of sarcopenia, allowing for timely interventions that enhance patient quality of life.
How similar studies have gone: While the use of ultrasound in diagnosing sarcopenia is gaining interest, this specific AI-assisted approach is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \> 50 years of age * Patients with suspected sarcopenia, for example, who needed assistance with walking, rising from a chair, or climbing stairs; recently had a history of falls walking; recent unintentional weight loss Exclusion Criteria: * Amputated arm or leg * Severe oedema (oedema higher than knee level) * Implantable pacemaker * Impaired consciousness, poor general health, or other reasons that would prevent the individual from completing the study
Where it's running
-
Xinyi Tang
Chengdu, Sichuan, China Recruiting
Study contacts
- Principal investigator: Xinyi Tang, Dr. — Department of Medical Ultrasound, West China Hospital, Sichuan University
- Study coordinator: Xinyi Tang, Dr.
- Email: tangxinyi1996@outlook.com
- Phone: +8615680819215
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Assessing muscle loss in lung cancer patients using imaging techniques
This study is testing a new way to use ultrasound and scans to find muscle loss in lung cancer patients to see if catching it early can help improve their treatment and recovery.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Ultrasound-guided nasal bone fracture reduction
This study tests whether using ultrasound to guide nasal bone fracture reduction can improve accuracy and outcomes for people with recent nasal injuries.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
-
GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes
This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.
-
Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis
We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.